Search ARM

Other Industry Events

Regenerative Medicine: Transitioning Therapeutics from Cells to the Clinic

February 22, 2016

Click here to register—ARM members use REGMED20 to get a 20% discount!

Monday, February 22, 2016

9:00 AM

Opening Remarks
Sonya Dougal, PhD, New York Academy of Sciences
Jane Lebkowski, PhD, Asterias Biotherapeutics

9:15 AM

iPSC-based Cell Therapy: Issues and Solutions
Mahendra Rao, PhD, Wake Forest University School of Medicine

9:55 AM

Engineering Genetic Cures: Genome Editing of Stem Cells
Edward Lanphier, Sangamo BioSciences Inc

10:35 AM

Networking Coffee Break

10:55 AM

Stem Cell Transplantation for Neurodegenerative Disease: The Case for ALS
Jonathan Glass, MD, Emory ALS Center

11:35 AM

John F. DiPersio, MD, PhD, Washington University School of Medicine

12:15 PM

Networking Lunch and Poster Session

1:15 PM

Jane S Lebkowski, PhD, Asterias Biotherapeutics

1:55 PM

Mechanism of Action of PLX – Placental-Derived Cellular Therapy
Racheli Ofir, PhD, Pluristem LTD

2:35 PM

Development of Stem-Cell Derived, Macroencapsulated Islet Replacement for Type 1 Diabetes
Thomas Schulz, PhD, ViaCyte, Inc.

3:15 PM

Networking Coffee Break

3:35 PM

Neural Stem Cell Treatment for Stroke Disability
John Sinden, PhD, ReNeuron Limited

4:15 PM

Kathleen Tsokas, Esq, Janssen/Johnson & Johnson

4:55 PM

Closing Remarks and Poster Award Presentation
George Zavoico, PhD, JonesTrading Institutional Services

5:00 PM

Networking Reception

6:00 PM